Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Nov 15;63(11):519-525.
doi: 10.2176/jns-nmc.2023-0090. Epub 2023 Aug 30.

Incidence and Outcomes of Aneurysmal Subarachnoid Hemorrhage: A Multicenter Retrospective Registry-based Descriptive Trial in Kobe City

Tsuyoshi Ohta  1 , Shirabe Matsumoto  1 , Ryu Fukumitsu  1 , Hirotoshi Imamura  1 , Hidemitsu Adachi  2 , Yoshie Hara  3 , Kohkichi Hosoda  4 , Hidehito Kimura  5 , Kazuyuki Kuwayama  6 , Takashi Mizowaki  7 , Yasuhiko Motooka  8 , Shiro Miyata  9 , Narihide Shinoda  10 , Yasushi Ueno  11 , Ikuya Yamaura  12 , Yasuhisa Yoshida  12 , Chiaki Sakai  13 , Nobuyuki Sakai  13
Affiliations
Multicenter Study

Incidence and Outcomes of Aneurysmal Subarachnoid Hemorrhage: A Multicenter Retrospective Registry-based Descriptive Trial in Kobe City

Tsuyoshi Ohta et al. Neurol Med Chir (Tokyo). .

Abstract

The current study aims to evaluate the incidence and results of aneurysmal subarachnoid hemorrhage (aSAH) throughout Kobe City. Based on a multicenter retrospective registry-based descriptive trial involving all 13 primary stroke centers in Kobe City, patients with aSAH treated between October 2017 and September 2019 were studied. A total of 334 patients were included, with an estimated age-adjusted incidence of 11.12 per 100,000 person-years. Curative treatment was given to 94% of patients, with endovascular treatment (51%) preferred over surgical treatment (43%). Of the patients, 12% were treated by shunt surgery for sequential hydrocephalus with a worse outcome at 30 days or discharge (14% vs. 46%, odds ratio (OR): 0.19, 95% confidence interval (CI): 0.088-0.39, p-value <0.001). As for vasospasm and delayed cerebral ischemia, most patients were given intravenous fasudil infusion (73%), with endovascular treatment for vasospasm in 24 cases (7.2%). The fasudil group had more good outcomes (42% vs. 30%, OR: 1.64, 95% CI: 0.95-2.87, p-value = 0.075) and significantly less death (3.3% vs. 35%, OR: 0.064, 95% CI: 0.024-0.15, p-value <0.001) at 30 days or discharge. Mortality rose from 12% at 30 days or discharge to 17% at 1 year, but neurological function distribution improved over time (modified Rankin Scale 0-2 was 39% at 30 days or discharge, 53% at 60 days, and 63% at 1 year). Our retrospective registered trial presented various statistics on aSAH, summarizing the current treatment status and prognosis.

Keywords: hydrocephalus; intracranial aneurysm; intracranial vasospasm; prognosis; subarachnoid hemorrhage.

PubMed Disclaimer

Conflict of interest statement

Dr. Ohta has received lecturer's fees from Medtronic Japan, Daiichi Sankyo, Johnson & Johnson, Terumo, Stryker Japan, Tokai Medical, Otsuka, Takeda, Eisai, Kaneka, Bristol-Myers Squibb, AstraZeneca, Japan Lifeline, Kowa, Nipro, Century Medical, and Idorsia outside of the submitted work.

Dr. Imamura has received lecturer's fees from Medtronic Japan, Daiichi Sankyo, Johnson & Johnson, Terumo, Stryker Japan, and Asahi Intecc outside of the submitted work.

Dr. Sakai has received a research grant from Biomedical Solutions, Medtronic, Terumo, and TG Medical; lecturer's fees from Asahi-Intec, Biomedical Solutions, Kaneka, Medtronic, Idorsia, and Terumo; and membership on the advisory boards for Johnson & Johnson, Medtronic, and Terumo outside the submitted work.

The other authors do not declare any conflicts of interest.

All authors have registered online self-reported COI Disclosure Statement Forms through the website for JNS members.

Figures

Fig. 1
Fig. 1
Time course of mRS distribution from 30 days or discharge to 1 year.
See this image and copyright information in PMC

References

    1. Mackey J, Khoury JC, Alwell K, et al. : Stable incidence but declining case-fatality rates of subarachnoid hemorrhage in a population. Neurology 87: 2192-2197, 2016 - PMC - PubMed
    1. Lord AS, Fernandez L, Schmidt JM, et al. : Effect of rebleeding on the course and incidence of vasospasm after subarachnoid hemorrhage. Neurology 78: 31-37, 2012 - PMC - PubMed
    1. Connolly ES Jr, Rabinstein AA, Carhuapoma JR, et al. : Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 43: 1711-1737, 2012 - PubMed
    1. Tenny S, Boktor SW: Incidence. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 Jan. https://www.ncbi.nlm.nih.gov/books/NBK430746/ (Accessed Apr 14 2022)
    1. https://www.city.kobe.lg.jp/a47946/shise/toke/toukei/jinkou/suikeijinkou.... https://www.city.kobe.lg.jp/a47946/shise/toke/toukei/jinkou/suikeijinkou...

Publication types